New York, NY, June 20, 2025 (GLOBE NEWSWIRE) -- GuruNanda, a competitor in the oral care industry, challenged express and implied claims for Crest’s Pro-Health Gum Detoxify toothpaste appearing on the product label, on the Crest website, and on third-party product pages, including Amazon and Walgreens. “Gum Detoxify” GuruNanda argued that the “Gum Detoxify” product name is understood by consumers to mean the toothpaste will remove all toxins and harmful substances from gums, including tobacco, heavy metals ...

MasterCraft Boat (MCFT) Q3 2025 Earnings Call May 07, 2025 08:30 AM ET Company Participants Scott Kent - VP - Finance & Incoming CFOBrad Nelson - CEO & DirectorTim Oxley - Vice President, Chief Financial Officer, Treasurer and SecretaryMartin Mitela - Senior Equity Research AssociateAdam Fox - Equity Research AssociateEric Wold - Executive Director, Equity Research Conference Call Participants Craig Kennison - Director of Research Operations & Senior Research AnalystAnna Glaessgen - Senior Research Analyst ...

Core Insights - The article compares Procter & Gamble (PG) and Colgate-Palmolive (CL), highlighting their market positions, financial performance, and strategic priorities within the consumer-packaged goods (CPG) industry [1][2]. Procter & Gamble (PG) - PG operates in over 180 countries with a market capitalization close to $400 billion, offering a diverse product lineup including Tide, Pampers, Gillette, and Olay, which provides a competitive advantage [3]. - In Q3 fiscal 2025, PG reported earnings per share (EPS) of $1.54, meeting analyst expectations, while maintaining or growing market share in seven of its ten core categories [4]. - The company focuses on premiumization and innovation, launching high-performance products and investing in advertising rather than discount promotions, which supports long-term brand strength [5]. - PG anticipates approximately $200 million in after-tax headwinds from commodity costs and foreign exchange in fiscal 2025, alongside projected tariff-related costs of $1-$1.5 billion annually [6]. - The company plans to return $16-17 billion to shareholders through dividends and buybacks, demonstrating a commitment to long-term value creation [7]. Colgate-Palmolive (CL) - CL is a leader in oral care with a 41% share of the global toothpaste market and a 32% share in manual toothbrushes, while also expanding into pet nutrition and skincare [9][10]. - In Q1 2025, CL reported sales exceeding $4.91 billion, beating estimates despite a 3% year-over-year decline, with an EPS of 91 cents also surpassing expectations [11]. - The company expects $200 million in incremental tariff impacts in 2025 but is mitigating these through supply-chain flexibility and productivity gains, having invested $2 billion in U.S. supply-chain upgrades over the past five years [12]. - CL maintains a focus on advertising ROI and AI-driven analytics to optimize spending while continuing to innovate and premiumize its offerings [13]. - The company is positioned to deliver sustainable shareholder value through its strong balance sheet and disciplined execution, despite short-term pressures [14][26]. Financial Estimates - For fiscal 2025, PG's sales and EPS are expected to grow by 0.4% and 3%, respectively, with EPS estimates down by 1.2% in the past week [15]. - CL's sales and EPS estimates suggest year-over-year growth of 0.6% and 1.4%, with EPS estimates down by 0.5% recently [18]. - Both companies have experienced downward estimate revisions, but CL's revisions are less severe compared to PG [20]. Price Performance & Valuation - Year-to-date, PG shares have declined by 3.1%, while CL stock has gained 1.4% [21]. - PG is trading at a forward P/E multiple of 23.06X, below its five-year median of 23.65X, indicating a potentially undervalued position [23]. - CL's forward P/E multiple is at 24.47X, above its five-year median of 24.1X, reflecting its solid fundamentals and growth strategy [24]. Conclusion - PG's extensive global presence and diversified brand portfolio provide a foundation for long-term revenue stability, though it faces geopolitical and market-specific challenges [25]. - CL's strong brand equity and adaptability position it as an attractive investment option, particularly with lower tariff risks and solid fundamentals [27].

Astrazeneca (AZN) reported $13.59 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 7.2%. EPS of $1.24 for the same period compares to $1.03 a year ago.The reported revenue represents a surprise of -0.66% over the Zacks Consensus Estimate of $13.68 billion. With the consensus EPS estimate being $1.10, the EPS surprise was +12.73%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street ...

Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe. Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association bet ...

Procter & Gamble (PG) Q3 2025 Earnings Call April 24, 2025 08:30 AM ET Company Participants Andre Schulten - Chief Financial OfficerLauren Lieberman - Managing DirectorBryan Spillane - Managing Director - Equity ResearchDara Mohsenian - Managing Director - US Beverage/Household Products SectorsFilippo Falorni - Director - Equity ResearchBonnie Herzog - Managing Director Mark Astrachan - Managing DirectorOlivia Tong - Managing DirectorRobert Ottenstein - Senior Managing Director & PartnerKevin Grundy - Manag ...

导 语：投资者正在判断，过去两年美股近25%的年均涨幅所依赖的经济环境是否已显著恶化。 华尔街再次陷入对经济增长放缓的担忧之中。 这一市场走势反映出投资者正在努力判断，过去两年美股近25%的年均涨幅所依赖的经济环境是否 已显著恶化。尽管多数分析师并不指望股市今年还能延续如此强劲的涨势，但他们此前仍普遍认为 市场有望继续走高。 尽管市场对经济增长的担忧升温，但许多投资者仍认为，这一轮市场动荡不会比近年来的其他波动 更严重。一些人甚至认为，这次的风险相对可控，因为其主要来源是政府政策，而特朗普 （Trump）过去曾多次迅速调整政策，因此仍有可能随时逆转。 周三，白宫宣布汽车制造商将在新关税政策下获得针对加拿大和墨西哥进口的一个月豁免，消息传 出后，股市收复了部分周内跌幅。然而，自新政府上台以来，华尔街的担忧情绪一直在累积，尤其 是特朗普政府在推行关税政策和裁减政府雇员方面的激进行动，超出了市场预期。 目前，最糟糕的经济数据仍主要体现在"软数据"上，比如信心调查。 例如，美国经济咨询委员会（The Conference Board）发布的消费者信心指数在2月份出现了自2021 年以来的最大单月跌幅。此外，周一公布的 ...